Animal bites pose a major public health problem for children and adults worldwide (World Health Organization., 2018) and constitute up to 1% of all visits to emergency departments (Jaindl et al., 2016;Morzycki et al., 2019). The vast majority of bite injuries are caused by dogs and, to a lesser extent, by cats, monkeys, snakes and humans (Medeiros & Saconato, 2001;Williams et al., 2021). It has been estimated that the risk of being bitten by a domestic animal throughout life is approximately 50%, but only between 10% and 50% of injuries are reported to medical services (Pfortmueller et al., 2013).
Aim: The objective was to determine the prevalence of the potentially inappropriate antipsychotics and anticholinergics used in patients with Parkinson's disease. Materials & methods: A cross-sectional study identified the prescription of antipsychotics, anticholinergics and drugs for the treatment of Parkinson's disease. The anticholinergic burden was evaluated, and quetiapine and clozapine were considered to be adequate antipsychotics. Results: 2965 patients with Parkinson's disease were identified. The presence of psychiatric disorders and other neurological pathologies was associated with a greater probability of receiving potentially inappropriate antipsychotic prescriptions. The presence of greater number of comorbidities was associated with a greater probability of receiving anticholinergics. Conclusion: Older age and associated comorbidities, especially psychiatric and neurological comorbidities, increase the likelihood of patients with Parkinson's disease being prescribed antipsychotics and anticholinergics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.